InvaGen Pharmaceuticals Reports 205 Manufacturing Job Cuts
InvaGen Pharmaceuticals filed WARN notices reporting 205 Manufacturing layoffs on Oct. 9–10, 2026.
InvaGen Pharmaceuticals Reports Workforce Reductions
InvaGen Pharmaceuticals, Inc. filed WARN notices reporting layoffs in the Manufacturing sector covering the period of October 9 - October 10, 2026, according to a WARN filing with state regulators. The filings list a combined total of 205 employees affected across two notices submitted to state regulators.
Reported layoffs
Per a WARN filing with state regulators, InvaGen Pharmaceuticals, Inc. submitted two notices dated in connection with the October 9–10, 2026 window. One filing recorded 45 employees impacted and the second filing recorded 160 employees impacted. Location and further operational details were not included in the filings provided.
Timing and documentation
The WARN filings cited above are the source of the reported figures and timing; both notices were reported by a WARN filing with state regulators. No additional company statement or public summary accompanied the filings in the records supplied.
In summary, public WARN notices show InvaGen Pharmaceuticals, Inc. moving to reduce its manufacturing workforce by 205 employees via two filings covering the October 9–10, 2026 period.